JAMA Neurology has recently published a phase II clinical trial of 20 mg of atorvastatin in chronic subdural hematoma, with the intention of reducing the surgical risk. The result has been favorable. The study has been done exclusively in Chinese population. Although it will be necessary to confirm this in larger studies and in a non-oriental population, can it be an option?
Article Safety and Efficacy of Atorvastatin for Chronic Subdural Hem...
That is an interesting concept that should be tested in a larger cohort, It would be interesting to understand the basic theory behind using Statin in Chronic sub dural hematoma.
your point of testing it in non-oriental population is valid, to increase external validity of such results.
regards
Thanks for the comment. I agree with your appreciation, Mouhand. I have not yet been able to access the full text in the journal and I do not know the rationale of this clinical trial.
it seems quite intresting needs to go for more aggressive study design
- Badges
- Science topic
- Similar topics
- Linguistics
- Composition Studies
- Publisher